Emergent BioSolutions EBS
NYSE EBS
$6.29 -0.07 (-1.10%)
As of: Oct 20, 2026 · 3:59 PM EDT

Emergent BioSolutions (EBS) Short term Debt (2010 - 2019)

Updated

Emergent BioSolutions (EBS) recorded Short term Debt of $10.1 million in Q3 2019, unchanged from the prior quarter.

Analysis

Emergent BioSolutions (EBS) Short term Debt (2010 - 2019) Analysis & Trends

Starting with Q4 2010, Emergent BioSolutions' Short term Debt history includes 15 quarters.

  • Per Business Quant, the preceding three quarters came in at $10.1 million (Q2 2019), $10.1 million (Q1 2019) and $10.1 million (Q4 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Emergent BioSolutions 325.34 Mn -425.56 Mn 137.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 10.10 Mn
Jun 30, 2019 10.10 Mn
Mar 31, 2019 10.10 Mn
Dec 31, 2018 10.10 Mn
Sep 30, 2013 4.47 Mn
Jun 30, 2013 4.47 Mn
Mar 31, 2013 4.47 Mn
Dec 31, 2012 4.47 Mn
Sep 30, 2012 4.15 Mn
Jun 30, 2012 4.06 Mn
Mar 31, 2012 3.28 Mn
Dec 31, 2011 5.36 Mn
Sep 30, 2011 4.92 Mn
Jun 30, 2011 10.23 Mn
Dec 31, 2010 17.19 Mn
API Access

Emergent BioSolutions Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=EBS&period=max&api_key=YOUR_API_KEY